Bausch + Lomb Vision-Correction Surgery Platform Approved in U.S. by FDA

By Adriano Marchese

Bausch + Lomb said Monday that its laser-assisted vision correction surgery platform to treat nearsightedness was approved by the U.S. Food and Drug Administration.

The Canadian eye-health company said the FDA has approved the Teneo Excimer Laser Platform for laser-assisted in situ keratomileusis, also known as Lasik, vision correction surgery for myopia and myopic astigmatism.

Bausch + Lomb said that Teneo has been adopted in more than 50 countries around the world.

Write to Adriano Marchese at [e-mail]

(END) Dow Jones Newswires

01-08-24 0726ET